The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
Open accessAbstract
BACKGROUND: GP-BAR1, a member G protein coupled receptor superfamily, is a cell surface bile acid-activated receptor highly expressed in the ileum and colon. In monocytes, ligation of GP-BAR1 by secondary bile acids results in a cAMP-dependent attenuation of cytokine generation. AIMS: To investigate the role GP-BAR1 in regulating intestinal homeostasis and inflammation-driven immune dysfunction in rodent models of colitis. METHODS: Colitis was induced in wild type and GP-BAR1(-/-) mice by DSS and TNBS administration. Potential GP-BAR1 agonists were identified by in silico screening and computational docking studies. RESULTS: GP-BAR1(-/-) mice develop an abnormal morphology of colonic mucous cells and an altered molecular architecture of epithelial tight junctions with increased expression and abnormal subcellular distribution of zonulin 1 resulting in increased intestinal permeability and susceptibility to develop severe colitis in response to DSS at early stage of life. By in silico screening and docking studies we identified ciprofloxacin as a GP-BAR1 ligand. In monocytes, ciprofloxacin increases cAMP concentrations and attenuates TNFα release induced by TLR4 ligation in a GP-BAR1 dependent manner. Treating mice rendered colitic by TNBS with ciprofloxacin and oleanolic acid, a well characterized GP-BAR1 ligand, abrogates signs and symptoms of colitis. Colonic expression of GP-BAR1 mRNA increases in rodent models of colitis and tissues from Crohn's disease patients. Flow cytometry analysis demonstrates that ≈90% of CD14+ cells isolated from the lamina propria of TNBS-treated mice stained positively for GP-BAR1. CONCLUSIONS: GP-BAR1 regulates intestinal barrier structure. Its expression increases in rodent models of colitis and Crohn's disease. Ciprofloxacin is a GP-BAR1 ligand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“changes in the composition of the bile acid pool, an increase in colonic expression of GPBAR1 and a decrease in ileal activity of BAR have all been detected in patients suffering from IBD (Cipriani et al., 2011; Duboc et al., 2013; Lenz et al., 1976; Nijmeijer et al., 2011; Rutgeerts et al., 1979).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Cipriani et al., 2011
In the citing paper
“Gpbar1−/− mice, like their Nr1h4−/− counterparts, develop more severe disease than wildtype controls in several animal models of inflammatory disorder, including colitis, hepatitis and gastritis (Cipriani et al., 2011; C. Guo et al., 2015; Y.-D. Wang et al., 2011).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Cipriani et al., 2011
In the citing paper
“Mice treated with GP-BAR1 agonists (ciprofloxacin and oleanolic acid) abrogated the signs and symptoms of TNBS-induced colitis.117”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [117]
In the citing paper
“Importantly these mice were more susceptible to DSS- or TNBS-induced colitis.117”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Comparative Protein Structure Modeling of Genes and Genomes
Martí-Renom, M. A., Stuart, A. C., Fiser, A., Sánchez, R., Melo, F., & Šali, A. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.291 · Cited by 3,169
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Main-chain Bond Lengths and Bond Angles in Protein Structures
Laskowski, R. A., Moss, D. S., & Thornton, J. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1351 · Cited by 1,217
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 383
Bile Acids and the Potential Role in Primary Biliary Cirrhosis
Yang, H., & Duan, Z. (2016) · Digestion · doi:10.1159/000452300 · Cited by 35
Regulation of mononuclear phagocyte function by the microbiota at mucosal sites
Scott, N. A., & Mann, E. R. (2019) · Immunology · doi:10.1111/imm.13155 · Cited by 35
Keely, S. J., Urso, A., Ilyaskin, A. V., Korbmacher, C., Bunnett, N. W., Poole, D. P., & Carbone, S. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00125.2021 · Cited by 37
Hou, J.-J., Wang, X., Wang, Y.-M., & Wang, B.-M. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2018401 · Cited by 36
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis
Bernardi, F., D’Amico, F., Bencardino, S., Faggiani, I., Fanizza, J., Zilli, A., Parigi, T. L., Allocca, M., Danese, S., & Furfaro, F. (2024) · Pharmaceuticals · doi:10.3390/ph17030347 · Cited by 39
Caffaratti, C., Plazy, C., Méry, G., Tidjani, A.-R., Fiorini, F., Thiroux, S., Toussaint, B., Hannani, D., & Gouëllec, A. L. (2021) · Metabolites · doi:10.3390/metabo11060406 · Cited by 36
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier
Barbara, G., Barbaro, M. R., Fuschi, D., Palombo, M., Falangone, F., Cremon, C., Marasco, G., & Stanghellini, V. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.790387 · Cited by 41
Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology
Kumar, J., & Teckman, J. H. (2015) · Children · doi:10.3390/children2030358 · Cited by 33
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa
Distrutti, E., Santucci, L., Cipriani, S., Renga, B., Schiaroli, E., Ricci, P., Donini, A., & Fiorucci, S. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1041-8 · Cited by 33
Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity
Ranhotra, H. S., Flannigan, K. L., Brave, M., Mukherjee, S., Lukin, D. J., Hirota, S. A., & Mani, S. (2016) · Nuclear Receptor Research · doi:10.11131/2016/101199 · Cited by 37
Biagioli, M., & Fiorucci, S. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.003 · Cited by 33
Pathophysiology and Clinical Management of Bile Acid Diarrhea
Marasco, G., Cremon, C., Barbaro, M. R., Falangone, F., Montanari, D., Capuani, F., Mastel, G., Stanghellini, V., & Barbara, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113102 · Cited by 33
Bile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communication
Joyce, S. A., & O'Malley, D. (2022) · The Journal of Physiology · doi:10.1113/jp281727 · Cited by 32
Approaches to discern if microbiome associations reflect causation in metabolic and immune disorders
Basic, M., Dardevet, D. P., Abuja, P. M., Bolsega, S., Bornes, S., Caesar, R., Calabrese, F. M., Collino, M., Angelis, M. D., Gérard, P., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2107386 · Cited by 35
Interactions between noroviruses, the host, and the microbiota
Walker, F. C., & Baldridge, M. T. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.04.001 · Cited by 31
Yin, Y., Wan, J., Yu, J., & Wu, K. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad081 · Cited by 35
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Zhao, X., Qiu, Y., Liang, L., & Fu, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2456592 · Cited by 33
Hepatoprotective impact of the bile acid receptor TGR5
Merlen, G., Bidault, V., Kahale, N., Glénisson, M., Bedoya, J. U., Doignon, I., Garcin, I., Humbert, L., Rainteau, D. P., & Tordjmann, T. (2020) · Liver International · doi:10.1111/liv.14427 · Cited by 29
Tan, Y., Li, Y., Zhou, F., Guo, J., Wang, T., Shi, Y., Yang, Y., Lu, J., & Pei, G. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.04.007 · Cited by 30
Zheng, Y., Yue, C., Zhang, H., Chen, H., Liu, Y., & Li, J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s298495 · Cited by 32
Kocot, A. M., & Wróblewska, B. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.11.014 · Cited by 28
Ahmad, F., Saha, P., Singh, V., Wahid, M., Mandal, R. K., Mishra, B. N., Fagoonee, S., & Haque, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.135320 · Cited by 31
Biagioli, M., Marchianò, S., di Giorgio, C., Roselli, R., Bordoni, M., Bellini, R., Fiorillo, B., Sepe, V., Catalanotti, B., Cassiano, C., et al. (2023) · Hepatology · doi:10.1002/hep.32787 · Cited by 28
Self-citationOverview of the microbiota in the gut-liver axis in viral B and C hepatitis
Neag, M. A., Mitre, A. O., Cătinean, A., & Buzoianu, A. D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i43.7446 · Cited by 27
Biagioli, M., Marchianò, S., Giorgio, C. D., Bordoni, M., Urbani, G., Bellini, R., Massa, C., Khan, R. S. U., Roselli, R., Monti, M. C., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115900 · Cited by 28
Kida, T., Omori, K., Hori, M., Ozaki, H., & Murata, T. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209288 · Cited by 27
Ji, C., Xie, X., Yin, J., Qi, W., Chen, L., Bai, Y., Wang, N., Zhao, D., Jiang, X., & Jiang, H. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.001 · Cited by 29
TGR5 Protects Against Colitis in Mice, but Vertical Sleeve Gastrectomy Increases Colitis Severity
Garibay, D., Zaborska, K. E., Shanahan, M. T., Zheng, Q., Kelly, K. M., Montrose, D. C., Dannenberg, A. J., Miller, A. D., Sethupathy, P., & Cummings, B. P. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03707-9 · Cited by 25
Yu, W., Jiang, Y., Xu, H., & Zhou, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020442 · Cited by 26
Microbial metabolites and immunotherapy: Basic rationale and clinical indications
Kovtonyuk, L. V., & McCoy, K. D. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101755 · Cited by 25
Bile salt signaling and bile salt-based therapies in cardiometabolic disease
Groenen, C., Nguyen, T.-A., Paulusma, C. C., & van de Graaf, S. F. J. (2024) · Clinical Science · doi:10.1042/cs20230934 · Cited by 25
Bile acid–gut microbiota crosstalk in irritable bowel syndrome
Gu, Y., Li, L., Yang, M., Liu, T., Song, X., Qin, X., Xu, X. J., Liu, J., Wang, B., & Cao, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2058353 · Cited by 26
Ipharraguerre, I. R., Pastor, J. J., Gavaldà‐Navarro, A., Villarroya, F., & Mereu, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32107-9 · Cited by 26
Cholestatic liver diseases: An era of emerging therapies
Samant, H. V., Manatsathit, W., Dies, D. F., Shokouh-Amiri, H. M., Zibari, G. B., Boktor, M., & Alexander, J. S. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i13.1571 · Cited by 25
Wu, S., Romero‐Ramírez, L., & Mey, J. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30619 · Cited by 23
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain
Shahbazi, A., Sepehrinezhad, A., Vahdani, E., Jamali, R., Ghasempour, M., Massoudian, S., Negah, S. S., & Larsen, F. S. (2023) · Biomedicines · doi:10.3390/biomedicines11051272 · Cited by 25
Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
Dhonnabháín, R. N., Xiao, Q., & O’Malley, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.745190 · Cited by 25
Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
Ralli, T., Saifi, Z., Tyagi, N., Vidyadhari, A., Aeri, V., & Kohli, K. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2142091 · Cited by 22
Ghosh, S., Erickson, D., Chua, M. J., Collins, J., & Jala, V. R. (2024) · mSystems · doi:10.1128/msystems.01255-23 · Cited by 21
Fiorucci, S., Urbani, G., Giorgio, C. D., Biagioli, M., & Distrutti, E. (2024) · Cells · doi:10.3390/cells13191650 · Cited by 22
Bile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon
Jalil, A., Perino, A., Dong, Y., Imbach, J., Volet, C., Oton, E. V., Demagny, H., Plantade, L., Gallart‐Ayala, H., Ivanišević, J., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00202-w · Cited by 25
Liu, S., Yang, L., Zhang, Y., Chen, H., Li, X., Xu, Z., Du, R. F., Li, X., Ma, J., & Liu, D. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1335765 · Cited by 26
Domingue, J. C., Ao, M., Sarathy, J., & Rao, M. C. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00168.2016 · Cited by 21
Biagioli, M., Marchianò, S., Roselli, R., Giorgio, C. D., Bellini, R., Bordoni, M., Distrutti, E., Catalanotti, B., Zampella, A., Graziosi, L., et al. (2022) · Cells · doi:10.3390/cells11071187 · Cited by 22
Liao, C., Wang, D., Qin, S., Zhang, Y., Chen, J., Xu, R., Xu, F., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.677738 · Cited by 22
Li, Y., Wang, K., Ding, J., Sun, S., Ni, Z., & Yu, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.954684 · Cited by 21
Mini-review: microbiota have potential to prevent PEDV infection by improved intestinal barrier
Yang, S., Liu, G., Savelkoul, H. F. J., Jansen, C. A., & Li, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1230937 · Cited by 20
Marchianò, S., Biagioli, M., Roselli, R., Zampella, A., Giorgio, C. D., Bordoni, M., Bellini, R., Morretta, E., Monti, M. C., Distrutti, E., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101397r · Cited by 20
TGR5 ligands as potential therapeutics in inflammatory diseases
Pols, T. W. H., Eggink, H. M., & Soeters, M. R. (2014) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s40102 · Cited by 21
Villalona, G. A., Price, A., Blomenkamp, K., Manithody, C., Saxena, S., Ratchford, T. L., Westrich, M., Kakarla, V., Pochampally, S., Phillips, W., et al. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1167 · Cited by 21
Effects of bile acid metabolism on intestinal health of livestock and poultry
Jia, H., & Dong, N. (2024) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13969 · Cited by 19
Roles of Bile Acid-Activated Receptors in Monocytes-Macrophages and Dendritic Cells
Jia, H., He, X., Jiang, T., & Kong, F. (2025) · Cells · doi:10.3390/cells14120920 · Cited by 21
Honke, N., Shaabani, N., Hardt, C., Krings, C., Häussinger, D., Lang, P. A., Lang, K. S., & Keitel, V. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000456168 · Cited by 18
The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease
Shen, X. Z., Li, Y., Wang, D., & Sun, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690279 · Cited by 25
Thuy, V. T. T., Lim, C. W., Park, J. H., Ahn, C., & Kim, D. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01930j · Cited by 18
Role of Bile Acids and Gut Microbiota in Parenteral Nutrition Associated Injury
Manithody, C., van Nispen, J., Murali, V., Jain, S., Ashish, S., Armstrong, A. T., & Ajay, J. (2020) · Journal of Human Nutrition · doi:10.36959/487/286 · Cited by 18
Cipriani, S., Mencarelli, A., Bruno, A. M., Renga, B., Distrutti, E., Santucci, L., Baldelli, F., & Fiorucci, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02128.x · Cited by 18
Giorgio, C. D., Urbani, G., Marchianò, S., Biagioli, M., Bordoni, M., Bellini, R., Massa, C., Lachi, G., Cari, L., Morretta, E., et al. (2025) · Liver International · doi:10.1111/liv.16235 · Cited by 19
Microbial bile acid modifications: current understandings, key problems, and future perspectives
Zhang, H., Wen, J., Liu, X., Feng, Y., Liu, X., & Ning, K. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3019-2 · Cited by 20
Etherington, R. E., Millar, B. J. M., Innes, B. A., Jones, D. E., Kirby, J. A., & Brain, J. G. (2019) · FASEB BioAdvances · doi:10.1096/fba.2018-00046 · Cited by 16
Jin, Y., Pridgen, T. A., & Blikslager, A. T. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000550 · Cited by 17
Kennedy, M. S., & Chang, E. B. (2025) · Journal of Clinical Investigation · doi:10.1172/jci193969 · Cited by 17
Gastro-intestinal tract: The leading role of mucosal immunity
Steinert, A., Radulovic, K., & Niess, J. H. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14293 · Cited by 17
Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle?
Péan, N., Doignon, I., & Tordjmann, T. (2013) · Clinics And Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.12.005 · Cited by 17
Bile acid receptors link nutrient sensing to metabolic regulation
Li, J., & Li, T. (2017) · Liver Research · doi:10.1016/j.livres.2017.04.001 · Cited by 16
FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection
Kang, J., Kim, M., & Yim, M. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101051 · Cited by 16
Bile acid modulation of host immunity
Anh, N. B., Yang, X., & Hang, H. C. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70014 · Cited by 16
Sun, Q., Tang, Y., Dai, L., Tang, Z., Zhou, W., Wu, T., & Ji, G. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00820 · Cited by 15
Taurodeoxycholate ameliorates DSS-induced colitis in mice
Zou, Y., Ghaderpour, A., Munkhbileg, B., Seo, S., & Seong, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110628 · Cited by 15
Essential roles of bile acid receptors FXR and TGR5 as metabolic regulators
Jacinto, S. H., & Fang, S. (2014) · Animal Cells and Systems · doi:10.1080/19768354.2014.987318 · Cited by 15
Duodenal bile acids as determinants of intestinal mucosal homeostasis and disease
Keely, S., & Talley, N. J. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13854 · Cited by 15
Sui, K., Tveter, K. M., Bawagan, F. G., Buckendahl, P., Martinez, S. A., Jaffri, Z. H., MacDonell, A. T., Wu, Y., Duran, R. M., Shapses, S. A., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.900667 · Cited by 16
Zhou, S., Li, Y., Hu, L., Qin, W., Cao, Y., Tang, Z., Li, H., Hu, X., Fang, Z., Li, S., et al. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12560 · Cited by 14
Myszor, I. T., Lapka, K., Hermannsson, K., Rekha, R., Bergman, P., & Gudmundsson, G. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-57251-3 · Cited by 12
Xiao, Y., Jia, Y., Liu, W., Niu, C., Mai, Z., Dong, J., Zhang, X.-S., Yuan, Z., Ji, P., Wei, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399829 · Cited by 14
Coutiño-Hernández, D., Sánchez‐Tapia, M., Leal-Vega, F. J., Bobadilla-del-Valle, M., Ledezma, H., Cervantes, R., Pedraza‐Chaverrí, J., Granados‐Portillo, O., Díaz, D., Antunes‐Ricardo, M., et al. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110856 · Cited by 14
Feng, D., Chen, B., Zeng, B., Xiao, L., Yan, J., Yang, T., Zhu, J., Li, T., Wang, L., Wei, H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111274 · Cited by 14
Bile Acid-Induced Liver Injury in Cholestasis
Li, T., & Chiang, J. Y. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_7 · Cited by 14
Bile acid alterations associated with indolent course of inflammatory bowel disease
Liu, C., Zhan, S., Li, N., Tu, T., Lin, J., Li, M., Chen, M., Zeng, Z., & Zhuang, X. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2200518 · Cited by 13
Biagioli, M., Giorgio, C. D., Morretta, E., Bellini, R., Massa, C., Urbani, G., Bordoni, M., Marchianò, S., Lachi, G., Sepe, V., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107403 · Cited by 14
Perrigoue, J., Das, A., & Mora, J. R. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360685 · Cited by 13
Oral pathogens meet the gut microbiome: new mechanistic insights on systemic disease
Gan, G., Chen, R., Zheng, P., Long, K., Ma, K. K., Sulaiman, J. E., & Huang, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1673512 · Cited by 16
Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome
Deng, X., Xiao, L., Luo, M., Xie, P., & Xiong, L. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16159 · Cited by 16
Xie, X., Dong, J., Lu, G., Gao, K., Li, X., Mao, W., Chen, F., Tong, Z., Li, B., & Li, W. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01243-w · Cited by 11
Shi, H., Chen, X.-Y., Chen, X., Wu, Z., Li, J.-Y., Sun, Y.-Q., Shi, D.-X., & Li, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.812386 · Cited by 12
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis
Marino, S. D., Finamore, C., Biagioli, M., Carino, A., Marchianò, S., Roselli, R., Giorgio, C. D., Bordoni, M., Leva, F. S. D., Novellino, E., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00636 · Cited by 12
The link between gut microbiota and multiple sclerosis from the perspective of barrier function
Ren, J., Niu, Z., Wang, J., Guo, J., Hao, H.-J., Gao, F., Liu, R., & Wang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652796 · Cited by 13
Guo, Q., Liú, W., Zhao, L., Sui, Y., Zhao, H., Liu, Y., Mu, C., & Wang, X. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109593 · Cited by 11
Fan, Y., Li, Y., Gu, X., Chen, N., Chen, Y., Fang, C., Wang, Z., Yin, Y., Deng, H., & Dai, L. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003430 · Cited by 11
Tolufashe, G. F., Lawal, M. M., Govender, K. K., Shode, F. O., & Singh, T. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.107900 · Cited by 11
Beyond lipids: Novel mechanisms for parenteral nutrition–associated liver disease
Wichman, B. E., Nilson, J., Govindan, S., Chen, A., Jain, A., Arun, V., Derdoy, J., Krebs, J., & Jain, A. K. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10830 · Cited by 11
Zhu, H., Wang, K., Chen, S., Kang, J., Guo, N., Chen, H., Liu, J., Wu, Y., He, P., Tu, Y., et al. (2022) · Nutrients · doi:10.3390/nu14163413 · Cited by 11
Lu, X., Fan, Y., Peng, Y., Pan, W., Du, D., Xu, X., Li, N., He, T., Nie, J., Shi, P., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00794-w · Cited by 12
Xue, H., Li, P., Guo, J., Chen, T., Li, S.-F., & Zhang, L. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101042 · Cited by 11
Li, S., Feng, W., Wu, J., Cui, H., Wang, Y., Liang, T., An, J., Chen, W., Guo, Z., & Lei, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169096 · Cited by 10
Bile Acids in Control of the Gut-Liver-Axis
Hild, B., Heinzow, H. S., Schmidt, H., & Maschmeier, M. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1330-9644 · Cited by 10
Sharkey, K. A., & Savidge, T. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.03.004 · Cited by 11
Lee, K. J., Kim, H., & Wang, J. (2025) · Bone · doi:10.1016/j.bone.2025.117644 · Cited by 9
Bile salt hydrolase activity as a rational target for MASLD therapy
Jones, E. V., Wang, Y., Wei, W., Reed, J. C., Chaudhari, S. N., Li, D. K., Boursier, J., Lang, S., Demir, M., Diehl, A. M., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2025.2608437 · Cited by 12
Rangel-Torres, B. E., García-Montoya, I. A., Rodríguez‐Tadeo, A., & Jiménez-Vega, F. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-10012-y · Cited by 9
Metadata
- Authors
- Cipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- University of Salerno (IT)
- Azienda Ospedaliera di Perugia (IT)
- Corresponding author
- Fiorucci, Stefano
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-27
- Volume
- 6
- Issue
- 10
- Pages
- e25637
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3203117
- OpenAlex
- W1970465623
- Cited by
- 382
- References
- 30
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 30 · 2023: 34 · 2022: 45 · 2021: 49 · 2020: 31 · 2019: 29 · 2018: 25 · 2017: 14 · 2016: 16 · 2015: 17 · 2014: 23 · 2013: 19 · 2012: 11
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-01-29)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- TGR5, bile acid receptors, colitis, intestinal barrier integrity, tight junctions, intestinal permeability, ciprofloxacin, oleanolic acid, cAMP signaling, TNF-α, TLR4, monocytes, Crohn's disease, DSS-induced colitis, TNBS-induced colitis, lamina propria
- MeSH terms
- Animals, Cholera Toxin, Ciprofloxacin, Colitis, Haptoglobins, Immunity, Intestinal Mucosa, Ligands, Permeability, Protein Precursors, Mice, Knockout, Tight Junctions, Receptors, G-Protein-Coupled, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review